Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency
- 31 March 1989
- journal article
- case report
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 83 (3) , 677-682
- https://doi.org/10.1016/0091-6749(89)90082-1
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Autoantibody-Mediated Acquired Deficiency of C1 InhibitorNew England Journal of Medicine, 1987
- IgG-Antikörperbildung gegen Cī-Inhibitor als Ursache lebensbedrohlicher AngioödemeDeutsche Medizinische Wochenschrift (1946), 1987
- Need for additional safety assays for heat-treated plasma protein fractionsTrends in Pharmacological Sciences, 1986
- An IgG autoantibody which inactivates C1¯-inhibitorNature, 1986
- Acquired C1-Inhibitor Deficiency Associated with Antiidiotypic Antibody to Monoclonal ImmunoglobulinsNew England Journal of Medicine, 1985
- Hereditäres angioneurotisches Ödem: Klinik, Diagnostik, Patientenführung und medikamentöse TherapieDeutsche Medizinische Wochenschrift (1946), 1984
- C1 INH Concentrate in the Therapy of Hereditary AngioedemaAllergy, 1983
- Replacement Therapy in Hereditary AngioedemaNew England Journal of Medicine, 1980
- Half‐life of CINH in hereditary angioneurotic oedema (HAE)*Clinical and Experimental Allergy, 1975
- Hereditary angioneurotic edema: II. Deficiency of inhibitor for serum globulin permeability factor and/or plasma kallikreinJournal of Allergy, 1962